Writing treatment notes
Week 6 Discussion 1: Writing Treatment Notes
Psychiatric SOAP
|
Criteria |
Clinical Notes |
|
Subjective |
Chief Compliant : Presented to appointment by request of his mom because “my grades are getting worse.” Patient Name: Cory DOB : Patient reports he just turned 16 years old. Sex : Male Preference for pronouns: Not mentioned in video. Location of interview : Living room. People present for interview : DNP Nursing Student (Georgina) and Patient (Cory) History of Present Illness : Reports difficulty concentrating in school. Reports grades are slipping. Reports he is easily distracted. Reports he regularly neglects to get his work done or to bring his books home. Reports little interest in his classes except from gy class and trades. Reports his instructors give him criticism that he makes "indiscreet missteps." Reports he doesn't take notes in class and assuming he does, he frequently neglects to bring notes home and experiences difficulty finishing his schoolwork. Reports frequent impulsivity, expressing that he frequently makes a minute ago arrangements with his friends. Reports low mood at present due to not having the option to play sports because of low evaluations. Reports getting a charge out of being truly dynamic outside Reports he often forgets his passwords or loses things in his room. Medical History : No prior medication used mentioned during interview. Denies prior hospitalizations. No mention of surgical procedures. Psychiatric History: Denies prior psychiatric hospitalizations. Denies seeing counselor in the past. Denies any prior self-injurious behaviors. Denies suicidal or homicidal thoughts. Denies A/H. Possible differential diagnosis of attention deficient hyperactivity disorder. Medication History : None Social History : No current job. Legal history not mentioned. Lives with parents and sister. Current high school sophomore. Substance Use : Not mentioned in video. Allergies : Bees. |
|
Include chief complaint, subjective information from the patient, names and relations of others present in the interview, and basic demographic information of the patient. HPI, Past Medical and Psychiatric History, Social History. |
|
|
Objective |
Mini Mental Status Exam: Patient was able to correctly spell the word world backwards, repeat three words immediately and recalled the three words after questions. Oriented to person, place, month, and year. Risk assessment: Denies SI, SIB and HI. No reported history of domestic violence. Reports frustration due to his symptoms. Discussed differential diagnoses of ADHD. Due to his reported impulsivity, patient at risk for legal implications and future impulsive actions. According to Philipp-Wiegmann (2018), patients that are diagnosed with ADHD have a high-risk factor for criminal activity and legal difficulties, if not treated. Screening results : No screening tools used in video. Labs results : None Vital signs : None Review of Systems: Negative. |
|
This is where the “facts” are located. Include relevant labs, test results, vitals, and Review of Systems (ROS) – if ROS is negative, “ROS noncontributory,” or “ROS negative with the exception of…” Include MSE, risk assessment here, and psychiatric screening measure results. |
|
|
Assessment |
Working primary diagnosis : No formal diagnoses were discussed in the video. Differential diagnosis : F90.9-Attention deficient hyperactivity disorder F81.9-Developmental disorder of scholastic skills, unspecified F32.Depression Medical diagnosis : None Treatment options : Plan to review DSM-5 criteria for ADHD with patient to set up a formal diagnosis. . Academic testing to decide whether formative issue is available. Talk about both nonpharmacological and pharmacological designs for overseeing ADHD. Gain colateral from school to establish a plan. Think about IEP to help in individualized help. Obstacles to treatment : Distraction and absent mindedness may imply that patient forgets to follow up with providers and attend appointments. May have disgrace encompassing psychiatric diagnosis. |
|
Include your findings, diagnosis and differentials (DSM-5 and any other medical diagnosis) along with ICD-10 codes, treatment options, and patient input regarding treatment options (if possible), including obstacles to treatment. |
|
|
Plan |
Lab work : Obtain HR, BP, and EKG. Obtain weight, height, and BMI. Assess cardiac history and family history of cardiac disease Diagnosis: Utilize DSM-5 to confirm ADHD diagnosis. Rule out substance use disorder before prescribing a stimulant medication for ADHD to ensure safety of the patient. Medication options : Consider Adderall to reduce symptoms of distractedness, impulsiveness, diminished school execution and hyperactivity (Stahl, Muntner and Grady, 2017). Start Adderall tablet, by mouth, 10mg and monitor for side effects and effectiveness. Prior to starting drug, the patient should be educated on the side effects as an afterthought impacts and the two guardians and child should agree to the prescription. Adderall may cause side effects of anorexia, dry mouth, weight reduction, sleep deprivation, irritability, tremors and dizziness. (Stahl, Muntner and Grady, 2017). Following one week of observing the 10mg dose it very well might be expanded by 10 mg if necessary for further effectiveness (Stahl, Muntner and Grady, 2017). Non-pharmacological interventions : Get collateral data with school counseling services just as his educators to guarantee an individualized plan for progress is made. Assess to decide whether IEP plan is required. Moore et al., (2016) report that pulling kids out of the classroom is disruptive for social working and IEP plans should take into consideration individualized in-class interventions for the best achievement. Obtain collateral data from guardians on his earlier presentation at school and the advancement of his present manifestations. Referrals : Referral to obtain Neuropsychological Testing to assess for learning disability or ADHD diagnosis (Ng, Heinrich and Hodges, 2019). Referral to therapist for behavioral therapy interventions and kept monitoring of symptoms (Moore et al., 2016). Complimentary therapies: Evaluate patient's point of view on free treatments first. When to see patient next? I plan to meet this patient in about fourteen days to review neuropsychological testing results and confirm diagnosis. During that session, I plan on reviewing treatment alternatives.In the client decides to accept Adderall 10 mg, plan to meet in a week for evaluation. |
|
Include a specific plan, including medications & dosing & titration considerations, lab work ordered, referrals to psychiatric and medical providers, therapy recommendations, holistic options and complimentary therapies, and rationale for your decisions. Include when you will want to see the patient next. This comprehensive plan should relate directly to your Assessment. |
|
References
Ng, R., Heinrich, K., & Hodges, E. K. (2019). Brief Report: Neuropsychological Testing and Informant-Ratings of Children with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, or Comorbid Diagnosis. Journal of Autism & Developmental Disorders, 49(6), 2589–2596. https://doi.org/10.1007/s10803-019-03986-2
Moore, D. A., Gwernan-Jones, R., Richardson, M., Racey, D., Rogers, M., Stein, K., Thompson-Coon, J., Ford, T. J., & Garside, R. (2016). The experiences of and attitudes toward non-pharmacological interventions for attention-deficit/hyperactivity disorder used in school settings: a systematic review and synthesis of qualitative research. Emotional & Behavioral Difficulties, 21(1), 61–82. https://doi.org/10.1080/13632752.2016.1139296
Ng, R., Heinrich, K., & Hodges, E. K. (2019). Brief Report: Neuropsychological Testing and Informant-Ratings of Children with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, or Comorbid Diagnosis. Journal of Autism & Developmental Disorders, 49(6), 2589–2596. https://doi.org/10.1007/s10803-019-03986-2
Philipp-Wiegmann, F., Rösler, M., Clasen, O., Zinnow, T., Retz-Junginger, P., & Retz, W. (2018). ADHD modulates the course of delinquency: a 15-year follow-up study of young incarcerated man. European Archives of Psychiatry & Clinical Neuroscience, 268(4), 391–399. https://doi.org/10.1007/s00406-017-0816-8
Stahl, S. M., Muntner, N., & Grady, M. M. (2017). Stahl’s essential psychopharmacology: Prescriber's guide. Cambridge: Cambridge University Press.